Supplementary Protection Certificates (SPC):
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
München
C.H. Beck
2016
Oxford Hart 2016 Baden-Baden Nomos 2016 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Auf dem Umschlag: A handbook |
| Beschreibung: | XVIII, 241 Seiten |
| ISBN: | 9783848702992 9783406648564 9781849464864 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV040993073 | ||
| 003 | DE-604 | ||
| 005 | 20160127 | ||
| 007 | t | ||
| 008 | 130513s2016 |||| 00||| eng d | ||
| 020 | |a 9783848702992 |c Nomos |9 978-3-8487-0299-2 | ||
| 020 | |a 9783406648564 |c Beck |9 978-3-406-64856-4 | ||
| 020 | |a 9781849464864 |c Hart |9 978-1-84946-486-4 | ||
| 035 | |a (OCoLC)949933101 | ||
| 035 | |a (DE-599)BVBBV040993073 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-384 |a DE-M382 |a DE-19 |a DE-12 |a DE-703 | ||
| 082 | 0 | |a 340 | |
| 084 | |a PJ 2380 |0 (DE-625)136660: |2 rvk | ||
| 245 | 1 | 0 | |a Supplementary Protection Certificates (SPC) |c edited by Marco Stief, Dirk Bühler |
| 264 | 1 | |a München |b C.H. Beck |c 2016 | |
| 264 | 1 | |a Oxford |b Hart |c 2016 | |
| 264 | 1 | |a Baden-Baden |b Nomos |c 2016 | |
| 300 | |a XVIII, 241 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Auf dem Umschlag: A handbook | ||
| 610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Patentrecht |0 (DE-588)4044884-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 0 | 1 | |a Patentrecht |0 (DE-588)4044884-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Stief, Marco |0 (DE-588)1076874592 |4 edt | |
| 700 | 1 | |a Bühler, Dirk |0 (DE-588)1026679168 |4 edt | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025970832&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-025970832 | ||
Datensatz im Suchindex
| _version_ | 1804150316632899584 |
|---|---|
| adam_text | SURVEY OF CONTENTS
FOREWORD V
CONTRIBUTORS VII
ABBREVIATIONS XVII
PARTI
GENERALS OF THE SUPPLEMENTARY PROTECTION CERTIFICATE
IN THE EUROPEAN LAW
A. PURPOSE, HISTORY AND LEGAL CHARACTER OF THE CERTIFICATE 3
I. OVERVIEW 3
1. BACKGROUND AND ECONOMIC RELEVANCE OF THE SUPPLEMENTARY PROTECTION
CERTIFICATE 3
2. AREA OF APPLICATION 4
II. RELATIONSHIP BETWEEN GRANT OF THE PATENT AND AUTHORISATION UNDER
PHARMACEUTICAL LAW 5
1. OVERVIEW OF THE DRUG AUTHORISATION PROCEDURES 6
2. DIFFERENTIATION BETWEEN PREPARATORY ACTIONS AND ACTUAL AUTHORISATION
PROCEDURE 6
3. THE EARLY PATENT APPLICATION 7
4. THE REDUCTION OF THE PATENT DURATION AND ITS COUNTERMEASURES 8
5. POSSIBLE ALTERNATIVES TO THE SUPPLEMENTARY PROTECTION CERTIFICATE 9
III. HISTORY 10
IV. LEGAL CHARACTER 11
B. SUBSTANTIVE GRANTING PREREQUISITES 12
I. GENERAL 12
II. PRODUCT 12
III. BASIC PATENT 13
1. DISCREPANCY BETWEEN BASIC PATENT AND AUTHORISATION 15
2. MULTIPLE BASIC PATENTS AND PATENTEES 16
IV. FIRST MARKETING AUTHORISATION 16
1. GENERAL PRINCIPLES 16
2. SENIOR AND EXTRATERRITORIAL AUTHORISATIONS 18
V. NO EARLIER CERTIFICATE - MULTIPLE SPCS FOR THE SAME PRODUCT 19
C. CALCULATION OF TERM 22
I. GENERAL 22
II. RELEVANT DATE FOR THE CALCULATION OF TERM 23
1. GRANT OF THE BASIC PATENT 23
2. LODGING THE BASIC PATENT APPLICATION 23
3. GRANT OF THE FIRST MARKETING AUTHORISATION 24
III. NEGATIVE TERMS 25
D. SUBJECT MATTER AND SCOPE OF PROTECTION 27
I. GENERAL 27
II. SPECIFIC PROBLEMS OF THE SCOPE OF PROTECTION 27
1. SALT ISSUE 27
2. USE PATENTS 29
3. SUBSTANCE COMBINATIONS 32
E. RIGHTS, LIMITATIONS AND OBLIGATIONS 41
I. RIGHTS OF THE CERTIFICATE HOLDER 41
1. RIGHTS OF USE AND EXCLUSIVITY 41
2. LICENSES 41
3. RIGHT TO THE SPC (ART. 6 REGSPC) 42
II. LIMITATIONS AND OBLIGATIONS 43
XI
HTTP://D-NB.INFO/1027505716
SURVEY OF CONTENTS
F. GRANT PROCEDURE 44
I. GENERAL 44
II. APPLICATION 44
1. GENERAL APPLICATION REQUIREMENTS 44
2. FORM AND CONTENT OF THE APPLICATION 44
3. APPLICATION PERIOD 46
4. APPLICATION REGARDING THE TERM EXTENSION OF AN SPC 47
5. APPLICATION FEES 48
6. PUBLICATION OF AN APPLICATION NOTICE 48
III. GRANT AND ANNOUNCEMENT 49
IV. FEES TO MAINTAIN THE SPC 50
G. EXPIRY, INVALIDITY AND REVOCATION 51
I. REASONS FOR EXPIRY PURSUANT TO ART. 14 REGSPC 51
II. REASONS FOR INVALIDITY PURSUANT TO ART. 15 REGSPC 52
III. REVOCATION OF A TERM EXTENSION 53
IV. ANNOUNCEMENT 53
H. REMEDIES 54
PART II
SPECIALITIES IN OTHER JURISDICTIONS
I. THE SPC IN GERMANY 55
I. NATIONAL PHARMACEUTICAL AND PATENT LAW 55
II. APPLICATION OF THE ART. 3 REGSPC CONDITIONS 56
III. CALCULATION OF THE TERM OF THE SPC 60
IV. RIGHTS, LIMITATIONS AND OBLIGATIONS 60
V. SPC GRANT, TERMINATION AND REMEDIES 61
1. GRANT 61
2. TERMINATION 64
J. THE SPC IN THE UNITED KINGDOM 66
I. NATIONAL LAW RELATING TO SPCS 66
II. APPLICATION OF THE ART. 3 REGSPC CONDITIONS 67
1. ARTICLE 3(A) REGSPC 68
2. ARTICLE 3(B) REGSPC 74
3. ARTICLE 3(C) REGSPC 74
4. ARTICLE 3(D) REGSPC 75
5. THIRD PARTY MAS 76
III. SPC APPLICATION PROCEDURE 77
1. APPLICATIONS FOR SPCS 77
2. APPLICATIONS FOR SPC EXTENSIONS 79
IV. INVALIDATION OF SPCS AND/OR SPC EXTENSIONS 79
K. THE SPC IN FRANCE 81
I. FRENCH NATIONAL PATENTS AND PHARMACEUTICAL LAW 81
II. THE CONDITIONS FOR OBTAINING AN SPC 82
1. ARTICLE 3(A) OF THE REGULATION 82
2. ARTICLE 3(B) OF THE REGULATION 84
3. ARTICLE 3(C) OF THE REGULATION 84
4. ARTICLE 3(D) OF THE REGULATION 85
III. GRANT PROCEDURE FOR SPCS IN FRANCE 85
IV. SCOPE OF PROTECTION 86
V. DURATION OF SPCS 87
VI. WAIVER OF SPCS 88
VII. PAEDIATRIC EXTENSIONS 88
L. THE SPC IN ITALY 90
I. NATIONAL PHARMACEUTICAL AND PATENT LAW 90
II. SPC OBTAINING PROVISIONS AND TERM 92
III. SUBJECT MATTER AND SCOPE OF PROTECTION 93
XII
SURVEY OF CONTENTS
IV. RIGHTS, LIMITATIONS AND OBLIGATIONS 94
V. SPC GRANT, TERMINATION AND REMEDIES 95
1. GRANT 95
2. TERMINATION 97
M. THE SPC IN THE NETHERLANDS 98
I. NATIONAL PHARMACEUTICAL AND PATENT LAW 98
1. PATENTS 98
2. NLOC AND DUTCH PATENT REGISTER 98
3. MEDICINES EVALUATION BOARD 99
II.
SPC OBTAINING PROVISIONS AND TERM IN THE DUTCH CONTEXT 99
1. APPLICATION 99
2. PUBLICATION 100
3. GRANT PROCEDURE 100
4. THIRD PARTY OBSERVATIONS 100
III. SUBJECT MATTER AND SCOPE OF PROTECTION 101
1. PRODUCT PROTECTED 101
2. ONE SPC PER PATENT? 103
3. FURTHER MEDICAL USE 104
IV. RIGHTS, LIMITATIONS AND OBLIGATIONS 105
V. LICENSE 106
VI. TERMINATION AND REMEDIES 106
VII. COURT PROCEEDINGS . . 107
N. THE SPC IN SWITZERLAND 108
I. SOURCES OF LAW AND LEGISLATIVE HISTORY 109
1. PATENT LAW 109
2. PHARMACEUTICAL LAW 109
3. LEGISLATIVE HISTORY 110
II.
SUBSTANTIVE GRANTING PREREQUISITES 110
1. OVERVIEW 110
2. THE TERM PRODUCT ILL
3. PROTECTION BY A BASIC PATENT 113
4. FIRST MA OF THE PRODUCT 114
5. FIRST SPC FOR THE PRODUCT 116
6. TIME LIMIT FOR FILING THE APPLICATION 118
III. APPLICATION, EXAMINATION, GRANT, AND REMEDIES 118
1. APPLICATION AND FEES 118
2. EXAMINATION AND ANNOUNCEMENT 119
3. GRANT 119
4. REMEDIES 120
IV. SUBJECT-MATTER OF PROTECTION AND EFFECTS 120
1. SUBJECT-MATTER OF PROTECTION 120
2. EFFECTS 121
V. TERM OF PROTECTION * 121
1. GENERAL 121
2. PAEDIATRIC EXTENSION 122
VI. PREMATURE LAPSE AND SUSPENSION 122
VII. NULLITY 123
VIII. SWISS FEDERAL PATENT COURT 123
ANNEXES
ANNEX A: SELECTED DECISIONS OF THE EUROPEAN AND SWISS CASE LAW 125
AL. COURT OF JUSTICE OF THE EUROPEAN UNION 125
I. BIOGEN V. SMITHKLINEBEECHAM BIOLOGICALS, C-181/95 OF 23 JANUARY 1997
125
II. YAMANOUCHI V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS AND
TRADEMARKS, C-110/95 OF
12 JUNE 1997 125
III. IDARUBICIN FARMITALIA V. DEUTSCHES PATENT- UND MARKENAMT, C-392/97
OF 16 SEPTEMBER
1999 126
IV. OMEPRAZOL HASSLE V. RATIOPHARM, C-127/00 OF 11 DECEMBER 2003 126
V. PHARMACIA ITALIA V. DEUTSCHES PATENT- UND MARKENAMT, C-31/03 OF 19
OCTOBER 2004 128
XIII
SURVEY OF CONTENTS
VI. NOVARTIS NOVARTIS V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS AND
TRADEMARKS, C-207/03,
MINISTRE DE ECONOMIE V. MILLENIUM PHARMACEUTICALS, C-252/03 OF 24
JANUARY 2005 128
VII. MASSACHUSETTS INSTITUTE OF TECHNOLOGY V. DEUTSCHES PATENT- UND
MARKENAMT,
C-431/04 OF 4 MAY 2006 128
VIII. I-21 GERMANY V. ARCOR, C-392/04, C-422/04 OF 19 SEPTEMBER 2006 130
IX. YISSUM RESEARCH AND DEVELOPMENT COMPANY V. COMPTROLLER-GENERAL OF
PATENTS,
C-202/05 OF 17 APRIL 2007 130
X. AHP MANUFACTURING V. BUREAU VOOR DE INDUSTRIELE EIGENDOM, C-482/07 OF
3 SEPTEMBER
2009 131
XI. MEMANTINE SYNTHON V. MERZ PHARMA, C-195/09 OF 28 JULY 2011 131
XII. GALANTAMIN GENERICS UK V. SYNAPTECH, C-427/09 OF 28 JULY 2011 132
XIII. MEDEVA V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS AND TRADEMARKS,
C-322/10 OF 24
NOVEMBER 2011 132
XIV. GEORGETOWN UNIVERSITY V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS
AND TRADEMARKS,
C-422/10 OF 24 NOVEMBER 2011 133
XV. DAIICHI SANKYO COMPANY V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS
AND TRADEMARKS,
C-6/11 OF 25 NOVEMBER 2011 133
XVI. YEDA RESEARCH AND DEVELOPMENT COMPANY, AVENTIS HOLDINGS V.
COMPTROLLER-GENERAL OF
PATENTS, DESIGNS AND TRADEMARKS, C-518/10 OF 25 NOVEMBER 2011 134
XVII. UNIVERSITY OF QUEENSLAND V. COMPTROLLER-GENERAL OF PATENTS,
DESIGNS AND TRADEMARKS,
C-630/10 OF 25 NOVEMBER 2011 134
XVIII. MERCK SHARPE & DOHME V. DEUTSCHES PATENT- UND MARKENAMT, C-125/10
OF 8 DECEMBER
2011 134
XIX. NOVARTIS V. ACTAVIS DEUTSCHLAND, C-574/11 OF 9 FEBRUARY 2012 AND
WITH THE SAME RESULT:
NOVARTIS V. ACTAVIS UK, C-442/11 OF 9 FEBRUARY 2012 135
XX. NEURIM PHARMACEUTICALS V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS
AND TRADEMARKS,
C-130/11 OF 19 JULY 2012 136
XXI. ASTRAZENECA V. EUROPEAN COMMISSION, C-457/10 OF 6 DECEMBER 2012 136
XXII. REFERRAL: ACTAVIS UK V. SANOFI, C-443/12 OF 3 OCTOBER 2012 137
XXIII. REFERRAL: ASTRAZENECA V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS
AND TRADEMARKS,
C-617/12 OF 18 DECEMBER 2012 139
XXIV. REFERRAL: BAYER CROPSCIENCE V. DEUTSCHES PATENT- UND MARKENAMT,
C-LL/13 OF
6 DECEMBER 2012 139
XXV. REFERRAL: GLAXOSMITHKLINE BIOLOGICALS V. COMPTROLLER-GENERAL OF
PATENTS, DESIGNS AND
TRADEMARKS, C-210/13 OF 21 MARCH 2013 139
XXVI. ELI LILLY AND COMPANY LTD. V. HUMAN GENOME SCIENCES INC., C-493/12
OF 12 DECEMBER
2013 140
XXVII. GEORGETOWN UNIVERSITY V. OCTROICENTRUM NEDERLAND (REFERRED TO AS
GEORGETOWN II IN THE
TEXT) C-484/12 OF 12 DECEMBER 2013 140
XXVIII. MERCK CANADA INC. V. ACCORD HEALTHCARE LTD. AND OTHERS, C-555/13
OF 13 FEBRUARY 2014 ... 141
XXIX. REFERRAL: SEATTLE GENETICS, C-471/14 OF 15 OCTOBER 2014 141
XXX. NOVARTIS V. ACTAVIS DEUTSCHLAND, C-574/11 OF 9 FEBRUARY 2012 141
XXXI. ACTAVIS V. BOEHRINGER INGELHEIM, C-577/13 OF 14 NOVEMBER 2013 141
XXXII. ARNE FORSGREN V. COMPTROLLER-GENERAL OF PATENTS, DESIGNS AND
TRADEMARKS, C-631/13 OF
15 JANUARY 2015 143
A2. GERMAN COURTS 145
FEDERAL COURT OF JUSTICE (BUNDESGERICHTSHOF, BGH) 145
I. TRIOXAN, X ZB 9/70 OF 6 JULY 1971 145
II. IDARUBICIN III, X ZB 21/00 OF 17 JULY 2001 145
III. SUMATRIPTAN, X ZB 12/01 OF 29 JANUARY 2002 145
IV. CUSTODIOL II, X ZR 73/01 OF 12 MARCH 2002 145
V. ANTI-HELICOBACTER-PRAPARAT, X ZB 1/08 OF 8 JULY 2008 146
VI. DOXORUBICIN, X ZB 4/08 OF 14 OCTOBER 2008 146
FEDERAL PATENT COURT (BUNDESPATENTGERICHT, BPATG) 146
VII. ABAMECTIN, 15 W (PAT) 71/97 OF 21 JUNE 1999 146
VIII. PORFIMER, 15 W (PAT) 59/03 OF 23 JUNE 2005 146
IX. FINASTERID, 3 NI 2/06 OF 15 MARCH 2007 147
X. SUBDIURETISCHE DOSIS, 3 NI 49/07 OF 16 JUNE 2009 147
XI. TENOFOVIR, 15 W (PAT) 24/07 OF 12 MAY 2011 147
XII. RANIBIZUMAB, 3 NI 28/11 OF 2 MAY 2012 147
XIII. INSULIN GLARGINE 14 W (PAT) 13/07 OF 31 MAY 2011 148
XIV
SURVEY OF CONTENTS
XIV. TELMISARTAN, 3 NI 5/13 OF 4 FEBRUARY 2013 148
DUSSELDORF REGIONAL COURT (LG DUSSELDORF) 148
XV. VALSARTAN, 4 B O 280/10 OF 8 MARCH 2011 148
A3. UK COURTS 150
COURT OF APPEAL OF ENGLAND 8C WALES 150
I. E I DU PONT NEMOURS & CO. V UK INTELLECTUAL PROPERTY OFFICE 2009 EWCA
CIV 966, 2010
R.P.C. 6 150
II. MEDEVA BV V COMPTROLLER GENERAL OF PATENTS, DESIGNS AND TRADE MARKS
2010 EWCA
CIV 700; 2010 R.P.C. 27 150
III. NEURIM PHARMACEUTICALS (1991) LTD V COMPTROLLER GENERAL OF PATENTS
2011 EWCA CIV 228;
2011 R.P.C. 19 150
IV. MEDEVA BV V COMPTROLLER GENERAL OF PATENTS, DESIGNS AND TRADE MARKS
2012 EWCA
CIV 523; 2012 R.P.C. 26 151
HIGH COURT OF ENGLAND 8C WALES 151
V. TAKEDA CHEMICAL INDUSTRIES LTD V COMPTROLLER GENERAL OF THE PATENT
OFFICE (NO.3) 2003
EWHC 649 (PAT); 2004 R.P.C. 3 151
VI. GILEAD SCIENCES, INC S SPC APPLICATIONS 2008 EWHC 1902 (PAT) 151
VII. ASTELLAS PHARMA INC V COMPTROLLER-GENERAL OF PATENTS 2009 EWHC 1916
(PAT) 152
VIII. NOVARTIS PHARMACEUTICALS UK LTD V MEDLMMUNE LTD 2012 EWHC 181
(PAT); 2012 F.S.R. 23 152
IX. ELI LILLY
& COMPANY V HUMAN GENOME SCIENCES INC 2012 EWHC 2290 (PAT) 153
X. ACTAVIS GROUP PTC EHF AND ACTAVIS UK LIMITED V SANOFI AND SANOFI
PHARMA
BRISTOL-MYERS SQUIBB SNC 2012 EWHC 2545 (PAT); 2013 R.P.C. 24 153
XI. ELI LILLY 8C COMPANY V HUMAN GENOME SCIENCES INC 2012 EWHC 2857
(PAT) 153
XII. DR REDDY S LABORATORIES (UK) LTD AND DR REDDY S LABORATORIES LTD V
WARNER-LAMBERT
COMPANY LLC 2012 EWHC 3715 (PAT); 2013 R.P.C. 31 154
XIII. GLAXOSMITHKLINE BIOLOGICALS SA V COMPTROLLER-GENERAL OF PATENTS,
DESIGNS AND
TRADE MARKS 2013 EWHC 619 (PAT); 2013 R.P.C. 26 154
XIV. ACTAVIS GROUP AND ACTAVIS UK V BOEHRINGER INGELHEIM PHARMA 2013
EWHC 2927 (PAT) 154
XV. ELI LILLY
8C COMPANY V HUMAN GENOME SCIENCES INC 2014 EWHC 2404 (PAT) 155
COMPTROLLER OF PATENTS 155
XVI. TAKEDA CHEMICAL INDUSTRIES LTD S APPLICATIONS 2004 R.P.C. 2 155
XVII. ABBOTT LABORATORIES SPC APPLICATION 2004 R.P.C. 20 156
A4. FRENCH COURTS 157
SUPREME COURT 157
I. DECISION OF 3 APRIL 2007 OF THE SUPREME COURT OF PARIS, DIAGNOSIS OF
AIDS 157
II. DECISION OF 19 MARCH 2013 OF THE SUPREME COURT, AZOXYSTROBINE +
FOLPEL 157
COURT OF APPEAL OF NANCY 158
III. DECISION OF 14JUNE 2010 OF THE COURT OF APPEAL OF NANCY, EXTRACT
OF TIMOTHY-GRASS 158
COURT OF APPEAL OF PARIS 158
IV. DECISION OF 15 FEBRUARY 2013 OF THE COURT OF APPEAL OF PARIS,
VARICELLA-ZOSTER VIRUS 158
V. DECISION OF 5 JULY 2013 OF THE COURT OF APPEAL OF PARIS,
PEGINTERFERON ALPHA 2A 158
VI. DECISION OF LLSEPTEMBER 2013 OF THE COURT OF APPEAL OF PARIS,
PERFLUTREN 159
AS. ITALIAN COURTS 160
I. DECISION 20/1978 CONSTITUTIONAL COURT 160
II. COURT OF MILAN IRBESARTAN HYDROCHLOROTIAZIDE 57598/12 OF 22/12/2012
160
III. COURT OF ROME CASE 23499 OF 19/05/2003 160
IV. COURT OF MILAN CASE 57598/2012 OF 10 JULY 2014 160
V. COMMISSIONE DEI RICORSI CASE 6895 OF 20/06/2002 160
VI. COMMISSIONE DEI RICORSI CASE 6353 OF 19/04/1996 161
VII. COMMISSIONE DEI RICORSI CASE 6491 OF 16/12/1997 AND 6497 OF
17/01/2000 161
A6. DUTCH COURTS 162
DISTRICT COURT OF THE HAGUE, ADMINISTRATIVE LAW DIVISION 162
I. GENZYME BIOSURGERY V. NLOC OF 3 JUNE 2004 162
II. STALLERGENES V. NLOC OF 4 NOVEMBER 2009 162
III. AVENTIS V. NLOC OF 28 MAY 2008 162
IV. ACTAVIS V. NLOC OF 23 SEPTEMBER 2009 162
XV
SURVEY OF CONTENTS
DISTRICT COURT OF THE HAGUE, CIVIL LAW DIVISION 163
V. SANOFI V. TEVA OF 14 SEPTEMBER 2012 (LATER REVOKED, SEE TEVA V.
SANOFI OF 27 AUGUST 2013)... 163
VI. MYLAN B.V. V. JANSSEN PHARMACEUTICALS INC. OF 11 DECEMBER 2013 163
COURT OF APPEAL OF THE HAGUE, CIVIL LAW DIVISION 163
VII. SKF V. CENTRAFARM OF 19 MAY 1994 163
VIII. PFIZER V. UVIT & PFIVER V. VGZ OF 24 JULY 2012 163
IX. APE V. PTC OF 23 APRIL 2013 163
X. TEVA V. SANOFI OF 27 AUGUST 2013 163
COUNCIL OF STATE 164
XI. YEDA V. NLOC OF 19 AUGUST 2009 164
XII. YEDA V. AVENTIS EN NLOC OF 27 MAY 2009 164
XIII. SYNGENTA V. NLOC OF 18 FEBRUARY 2015 164
A7. SWISS COURTS 165
FEDERAL ADMINISTRATIVE COURT 165
I. PANITUMUMAB , NO. B-3245/2010, DECISION OF 18 AUGUST 2011 OF THE
FEDERAL
ADMINISTRATIVE COURT 165
II. EXENATIDE , NO. B-1019/2010, DECISION OF 20 OCTOBER 2010 OF THE
FEDERAL ADMINISTRATIVE
COURT 165
III. ETANERCEPT , BVGE 2010/48, NO. B-3064/2008, DECISION OF 13
SEPTEMBER 2010 OF THE
FEDERAL ADMINISTRATIVE COURT 166
FEDERAL SUPREME COURT 167
IV. ALENDRONSAURE II , NO. 4A_52/2008, DECISION OF 29 APRIL 2008 OF THE
FEDERAL SUPREME
COURT 167
V. FLUOXETIN , NO. 4P.11/1999, DECISION OF 27 MAY 1999 OF THE FEDERAL
SUPREME COURT 167
VI. ARZNEIMITTEL , NO. 4A.7/1998, DECISION OF THE FEDERAL SUPREME COURT
OF 17 NOVEMBER
1998 167
VII. FOSINOPRIL , 124 III 375, DECISION OF THE FEDERAL SUPREME COURT OF
10 JULY 1998 168
FEDERAL APPEAL COMMISSION FOR INTELLECTUAL PROPERTY 169
VIII. DIFFERIN GEL , NO. PA 02/03, DECISION OF 21 JANUARY 2005 OF THE
FEDERAL APPEAL
COMMISSION FOR INTELLECTUAL PROPERTY 169
IX. CIDOSPORIN , NO. PA 03/97, DECISION OF THE FORMER FEDERAL APPEAL
COMMISSION FOR
INTELLECTUAL PROPERTY OF 30 APRIL 1999 169
ANNEX B: SELECTED LEGAL SOURCES 171
BL. INTERNATIONAL TREATIES 171
B2. EUROPEAN PRIMARY LAW 173
B3. EUROPEAN REGULATIONS 176
B4. EUROPEAN DIRECTIVES 193
B5. NATIONAL LAW 196
I. GERMANY 196
II. UNITED KINGDOM 204
III. FRANCE 208
IV. ITALY 213
V. NETHERLANDS 221
VI. SWITZERLAND 229
XVI
|
| any_adam_object | 1 |
| author2 | Stief, Marco Bühler, Dirk |
| author2_role | edt edt |
| author2_variant | m s ms d b db |
| author_GND | (DE-588)1076874592 (DE-588)1026679168 |
| author_facet | Stief, Marco Bühler, Dirk |
| building | Verbundindex |
| bvnumber | BV040993073 |
| classification_rvk | PJ 2380 |
| ctrlnum | (OCoLC)949933101 (DE-599)BVBBV040993073 |
| dewey-full | 340 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 340 - Law |
| dewey-raw | 340 |
| dewey-search | 340 |
| dewey-sort | 3340 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01629nam a2200421 c 4500</leader><controlfield tag="001">BV040993073</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160127 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">130513s2016 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783848702992</subfield><subfield code="c">Nomos</subfield><subfield code="9">978-3-8487-0299-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783406648564</subfield><subfield code="c">Beck</subfield><subfield code="9">978-3-406-64856-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781849464864</subfield><subfield code="c">Hart</subfield><subfield code="9">978-1-84946-486-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)949933101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040993073</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">340</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PJ 2380</subfield><subfield code="0">(DE-625)136660:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Supplementary Protection Certificates (SPC)</subfield><subfield code="c">edited by Marco Stief, Dirk Bühler</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="b">C.H. Beck</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Hart</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Baden-Baden</subfield><subfield code="b">Nomos</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 241 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Auf dem Umschlag: A handbook</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stief, Marco</subfield><subfield code="0">(DE-588)1076874592</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bühler, Dirk</subfield><subfield code="0">(DE-588)1026679168</subfield><subfield code="4">edt</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025970832&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025970832</subfield></datafield></record></collection> |
| id | DE-604.BV040993073 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:36:59Z |
| institution | BVB |
| isbn | 9783848702992 9783406648564 9781849464864 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025970832 |
| oclc_num | 949933101 |
| open_access_boolean | |
| owner | DE-384 DE-M382 DE-19 DE-BY-UBM DE-12 DE-703 |
| owner_facet | DE-384 DE-M382 DE-19 DE-BY-UBM DE-12 DE-703 |
| physical | XVIII, 241 Seiten |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | C.H. Beck Hart Nomos |
| record_format | marc |
| spelling | Supplementary Protection Certificates (SPC) edited by Marco Stief, Dirk Bühler München C.H. Beck 2016 Oxford Hart 2016 Baden-Baden Nomos 2016 XVIII, 241 Seiten txt rdacontent n rdamedia nc rdacarrier Auf dem Umschlag: A handbook Europäische Union (DE-588)5098525-5 gnd rswk-swf Patentrecht (DE-588)4044884-8 gnd rswk-swf Europäische Union (DE-588)5098525-5 b Patentrecht (DE-588)4044884-8 s DE-604 Stief, Marco (DE-588)1076874592 edt Bühler, Dirk (DE-588)1026679168 edt DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025970832&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Supplementary Protection Certificates (SPC) Europäische Union (DE-588)5098525-5 gnd Patentrecht (DE-588)4044884-8 gnd |
| subject_GND | (DE-588)5098525-5 (DE-588)4044884-8 |
| title | Supplementary Protection Certificates (SPC) |
| title_auth | Supplementary Protection Certificates (SPC) |
| title_exact_search | Supplementary Protection Certificates (SPC) |
| title_full | Supplementary Protection Certificates (SPC) edited by Marco Stief, Dirk Bühler |
| title_fullStr | Supplementary Protection Certificates (SPC) edited by Marco Stief, Dirk Bühler |
| title_full_unstemmed | Supplementary Protection Certificates (SPC) edited by Marco Stief, Dirk Bühler |
| title_short | Supplementary Protection Certificates (SPC) |
| title_sort | supplementary protection certificates spc |
| topic | Europäische Union (DE-588)5098525-5 gnd Patentrecht (DE-588)4044884-8 gnd |
| topic_facet | Europäische Union Patentrecht |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025970832&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT stiefmarco supplementaryprotectioncertificatesspc AT buhlerdirk supplementaryprotectioncertificatesspc |